Intrinsic Value of S&P & Nasdaq Contact Us

ORIC Pharmaceuticals, Inc. ORIC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.75
+106.6%

Stock Statistics — ORIC

ORIC Pharmaceuticals, Inc. (ORIC) has a market capitalization of $1.06B and trades at $10.53. The 52-week range is 3.895-14.93.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.2, Earnings Per Share (EPS) of $-1.47.

The stock has a beta of 1.36, operates in the Healthcare sector.

Trading Data
Current Price$10.53
52-Week Range3.895-14.93
Volume948.67K
Avg Volume (30D)1.97M
Market Cap$1.06B
Beta (1Y)1.36
Company
IPO Date2020-04-24
Employees122
CEOJacob Chacko
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS68622P1093
CUSIP68622P109
Income (Latest Year)
Gross Profit$-1.22M
EBITDA$-128.25M
Operating Income$-143M
Net Income$-129.47M
EPS$-1.47
EPS Diluted$-1.47
Shares Outstanding$87.79M
Balance Sheet (Latest Year)
Total Assets$411M
Current Assets$288.47M
Cash & ST Investments$281.49M
Total Liabilities$26.64M
Total Debt$11.55M
Net Debt$-34.12M
Total Equity$384.36M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-7.2
P/B Ratio2.75
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message